Show simple item record

dc.contributor.authorPorcello, Alexandre
dc.contributor.authorLaurent, Alexis
dc.contributor.authorHirt-Burri, Nathalie
dc.contributor.authorAbdel-Sayed, Philippe
dc.contributor.authorde Buys Roessingh, Anthony
dc.contributor.authorRaffoul, Wassim
dc.contributor.authorJordan, Olivier
dc.contributor.authorAllémann, Eric
dc.contributor.authorApplegate, Lee Ann
dc.date.accessioned2025-03-08T04:55:10Z
dc.date.available2025-03-08T04:55:10Z
dc.date.issued2022
dc.date.submitted2023-09-27T12:59:58Z
dc.identifierhttps://library.oapen.org/handle/20.500.12657/76457
dc.identifier.urihttps://doab-dev.siscern.org/handle/20.500.12854/180476
dc.description.abstractHyaluronan-based hydrogels are optimal candidates when developing novel combined advanced therapy medicinal products (cATMP), tissue engineering products (TEP), and medical devices. The key physico-chemical properties of hydrogels may hinder, mediate, or stimulate therapeutic potentials borne by standardised cellular substrates in regenerative medicine. Parallel to delivery system or scaffold development, hydrogel functionalisation may be advantageous in specific musculoskeletal interventions or topical applications (e.g. viscosupplementation, soft tissue volumetric supplementation, rehabilitation topical preparations). Optimised combination product developmental workflows enable pragmatic regulatory classification of cell-based preparations. Such aspects will be discussed, as well as sustainable transposition to industrialised production settings. Hyaluronan benefits from extensive hindsight in numerous human and veterinary applications, providing a highly versatile backbone for quasi-infinite structural modification and physico-chemical property modulation. This chapter provides an overview of critical product design considerations and possible therapeutic applications of versatile hyaluronan-based preparations intended for cell therapy delivery, combined with optimised autologous or allogeneic therapeutic cell sources (e.g. platelet-rich plasma, stem cells, banked primary foetal progenitors). Particular focus was set on specific parameters directly impacting product potential in terms of clinical translation and effectiveness for topical wound healing or sub-critical volumetric defect correction and repair stimulation in musculoskeletal regenerative medicine applications.
dc.languageEnglish
dc.rightsopen access
dc.subject.otherRegenerative medicine, Carbon nanotube, Block copolymers, Wound healing, Anticancer therapy, Particles used in imaging
dc.titleChapter 8 Hyaluronan-Based Hydrogels as Functional Vectors for Standardised Therapeutics in Tissue Engineering and Regenerative Medicine
dc.typechapter
oapen.identifier.doi10.1201/9781003153504-8
oapen.relation.isPublishedByfa69b019-f4ee-4979-8d42-c6b6c476b5f0
oapen.relation.isPartOfBook6e5b171f-19a7-41cf-beda-8e4818df3fd7
oapen.relation.isbn9780367721138
oapen.relation.isbn9780367721169
oapen.imprintCRC Press
oapen.pages31


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record